Alcoholic hepatitis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Durect Corporation, Novartis, Akaza Bioscience

September 22 19:32 2022
Alcoholic hepatitis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies - Durect Corporation, Novartis, Akaza Bioscience
DelveInsight’s “Alcoholic hepatitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Alcoholic hepatitis, historical and forecasted epidemiology as well as the Alcoholic hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Alcoholic hepatitis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Alcoholic hepatitis pipeline products will significantly revolutionize the Alcoholic hepatitis market dynamics.  

 

Alcoholic hepatitis Overview

Alcoholic hepatitis (AH), as the name suggests, is hepatitis – inflammation of the liver – due to excessive intake of alcohol. Patients typically have a history of heavy alcohol intake, about 8–10 drinks per day. It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to fibrosis progression, leading to cirrhosis.

Alcoholic hepatitis symptoms may present acutely after a large amount of alcoholic intake in a short period, or after years of excess alcohol intake. Signs and symptoms of alcoholic hepatitis include jaundice (yellowing of the skin and eyes), ascites (fluid accumulation in the abdominal cavity), fatigue, and hepatic encephalopathy (brain dysfunction due to liver failure). Mild cases are self-limiting, but severe cases have a high risk of death. 

 

Some of the key facts of the Alcoholic hepatitis Market Report: 

  • The Alcoholic hepatitis market size was estimated for USD 5.0 Million in the year 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • Diagnosed moderate-to-severe alcoholic hepatitis cases in the 7MM countries were 857,524 in 2021 
  • The United States had the highest prevalent alcoholic hepatitis population, with 346,159 cases in 2021 
  • Among future therapeutic directions, gene therapy, is perhaps the most appealing modality. Various genes involved in hepatic fibrogenesis, inflammatory response, and oxidative stress are overexpressed in alcoholic hepatitis. 
  • Key Alcoholic hepatitis Companies: Durect Corporation, Novartis, Akaza Bioscience, and others 
  • Key Alcoholic hepatitis Therapies: DUR-928, Canakinumab, TAK-242, and others 
  • The Alcoholic hepatitis epidemiology based on gender analyzed that there are more cases for Alcoholic Hepatitis in males than females 

 

Get a Free sample for the Alcoholic hepatitis Market Report 

 

Key benefits of the Alcoholic hepatitis Market report:

  1. Alcoholic hepatitis market report covers a descriptive overview and comprehensive insight of the Alcoholic hepatitis Epidemiology and Alcoholic hepatitis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Alcoholic hepatitis market report provides insights on the current and emerging therapies.
  3. Alcoholic hepatitis market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Alcoholic hepatitis market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Alcoholic hepatitis market.
  5.  

Discover more about therapies set to grab major Alcoholic hepatitis market share @ Alcoholic hepatitis market forecast 

 

Alcoholic hepatitis Epidemiology Segmentation:

The Alcoholic hepatitis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Alcoholic hepatitis
  • Prevalent Cases of Alcoholic hepatitis by severity
  • Gender-specific Prevalence of Alcoholic hepatitis
  • Diagnosed Cases of Episodic and Chronic Alcoholic hepatitis 

 

Alcoholic hepatitis Market  

The dynamics of the Alcoholic hepatitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

 

Download the report to understand which factors are driving Alcoholic hepatitis epidemiology trends @ Alcoholic hepatitis Epidemiological Insights 

 

Alcoholic hepatitis Market Drivers

  • Emerging Alcoholic hepatitis Therapies
  • Novel Alcoholic hepatitis Treatment Options
  • Higher Alcoholic hepatitis Patient Pool
  • Technological Advances

 

Alcoholic hepatitis Therapies and Key Companies

  • DUR-928: Durect Corporation
  • Canakinumab: Novartis
  • TAK-242: Akaza Bioscience 

 

Scope of the Alcoholic hepatitis Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Alcoholic hepatitis Companies: Durect Corporation, Novartis, Akaza Bioscience, and others
  • Key Alcoholic hepatitis Therapies: DUR-928, Canakinumab, TAK-242, and others
  • Alcoholic hepatitis Therapeutic Assessment: Alcoholic hepatitis current marketed and Alcoholic hepatitis emerging therapies
  • Alcoholic hepatitis Market Dynamics:  Alcoholic hepatitis market drivers and barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Unmet Needs, KOL’s views, Analyst’s views, Alcoholic hepatitis  Market Access and Reimbursement 

 

Alcoholic hepatitis Market Barriers

  • Higher Mortality
  • High Cost of Alcoholic hepatitis Treatment
  • Key Barriers to Drug Development

 

Table of Contents 

1. Alcoholic hepatitis Market Report Introduction

2. Executive Summary for Alcoholic hepatitis

3. SWOT analysis of Alcoholic hepatitis

4. Alcoholic hepatitis Patient Share (%) Overview at a Glance

5. Alcoholic hepatitis Market Overview at a Glance

6. Alcoholic hepatitis Disease Background and Overview

7. Alcoholic hepatitis Epidemiology and Patient Population

8. Country-Specific Patient Population of Alcoholic hepatitis 

9. Alcoholic hepatitis Current Treatment and Medical Practices

10. Alcoholic hepatitis Unmet Needs

11. Alcoholic hepatitis Emerging Therapies

12. Alcoholic hepatitis Market Outlook

13. Country-Wise Alcoholic hepatitis Market Analysis (2019–2032)

14. Alcoholic hepatitis Market Access and Reimbursement of Therapies

15. Alcoholic hepatitis Market drivers

16. Alcoholic hepatitis Market barriers

17.  Alcoholic hepatitis Appendix

18. Alcoholic hepatitis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Alcoholic hepatitis treatment, visit @ Alcoholic hepatitis Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

  Categories:
view more articles

About Article Author